<DOC>
	<DOCNO>NCT00504829</DOCNO>
	<brief_summary>The current study design test efficacy , safety tolerability LCP-AtorFen , combination atorvastatin fenofibrate .</brief_summary>
	<brief_title>Study Atorvastatin/Fenofibrate ( LCP-AtorFen ) Combination Therapy Dyslipidemia</brief_title>
	<detailed_description>This multicenter , randomize , double-blind , 12 week study 52-week open-label follow-up evaluate safety efficacy LCP-AtorFen ( combination atorvastatin fenofibrate ) treatment hyperlipidemia . After wash-out phase , eligible patient randomize 1:1:1 ratio either LCP-AtorFen , atorvastatin fenofibrate 12 week . After completion 12-week phase , eligible patient offer receive open-label LCP-AtorFen another 52 week .</detailed_description>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<criteria>1 . A diagnosis dyslipidemia ( nonHDLC &gt; 130 mg/dL Triglycerides &gt; equal 150 mg/dL &lt; equal 500 mg/dL ) . 2 . Subject may currently statin lipidlowering therapy must willing able washout 8 week fibrate highdose niacin , 6 week statin lowdose niacin per day , 4 week bile acid sequestrant , ezetimibe , &gt; 1000 mg fish oil per day . 3 . Other inclusion criterion might apply 1 . TGs &gt; 500 mg/dL . 2 . History coronary heart disease ( CHD ) , transient ischemic attack , stroke revascularization procedure six month prior . 3 . Presence aortic aneurysm resection aortic aneurysm within six month . 4 . Poorly control diabetes mellitus ( glycosylated hemoglobin &gt; 8.0 % ) diabetes mellitus require insulin therapy . 5 . Known lipoprotein lipase impairment deficiency Apo CII deficiency familial dysbetalipoproteinemia . 6 . History pancreatitis . 7 . Known allergy sensitivity statins fibrates . 8 . Poorly control hypertension . 9 . Other exclusion criterion might apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>LCP-AtorFen</keyword>
	<keyword>Non-HDL cholesterol</keyword>
	<keyword>Triglycerides</keyword>
	<keyword>HDL cholesterol</keyword>
	<keyword>LDL cholesterol</keyword>
	<keyword>Atorvastatin</keyword>
	<keyword>Fenofibrate</keyword>
</DOC>